The European Journal of Health Economics

2002 - 2025

Current editor(s): J.-M.G.v.d. Schulenburg

From:
Springer
Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ)
Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 12, issue 6, 2011

Budget impact analysis in economic evaluation: a proposal for a clearer definition pp. 499-502

Livio Garattini and Katelijne Vooren

Comparison of cost-weights scales methodologies in the perspective of a financing system based on pathologies pp. 503-508

M. Pirson, C. Delo, D. Martins and P. Leclercq

Cost efficiency of university hospitals in the Nordic countries: a cross-country analysis pp. 509-519

Emma Medin, Kjartan Anthun, Unto Häkkinen, Sverre Kittelsen, Miika Linna, Jon Magnussen, Kim Olsen and Clas Rehnberg

Do you believe in magic? Improving the quality of pharmacy services through restricting entry and aspirational contracts, the Irish experience pp. 521-531

Paul Gorecki

Direct costs of Alzheimer’s disease in Germany pp. 533-539

Peter Kiencke, Dietmar Daniel, Christine Grimm and Reinhard Rychlik

Exploring the relationship between costs and quality: Does the joint evaluation of costs and quality alter the ranking of Danish hospital departments? pp. 541-551

Anne Hvenegaard, Jacob Arendt, Andrew Street and Dorte Gyrd-Hansen

How removing prescription drugs from reimbursement lists increases the pharmaceutical expenditures for alternatives pp. 553-562

Özden Gür Ali and Başak Topaler

The impact of repeated cost containment policies on pharmaceutical expenditure: experience in Spain pp. 563-573

Iván Moreno-Torres, Jaume Puig-Junoy and Josep Raya

Cost-effectiveness of zoledronic acid in the prevention of skeletal-related events in patients with bone metastases secondary to advanced renal cell carcinoma: application to France, Germany, and the United Kingdom pp. 575-588

M. Botteman, M. Meijboom, I. Foley, J. Stephens, Y. Chen and S. Kaura

Market structure and hospital–insurer bargaining in the Netherlands pp. 589-603

R. Halbersma, Misja Mikkers, Evgenia Motchenkova and I. Seinen

Volume 12, issue 5, 2011

Pharmaceutical patents, R&D incentives and access to new drugs: new ways of progress at the crossroad pp. 393-395

Fernando Antoñanzas, Carmelo Juárez-Castelló and Roberto Rodríguez-Ibeas

Largely ignored: the impact of the threshold value for a QALY on the importance of a transferability factor pp. 397-404

Pepijn Vemer and Maureen Rutten- van Mölken

Discrimination in waiting times by insurance type and financial soundness of German acute care hospitals pp. 405-416

Christoph Schwierz, Achim Wübker, Ansgar Wübker and Björn Kuchinke

Hospital’s activity-based financing system and manager: physician interaction pp. 417-427

David Crainich, Hervé Leleu and Ana Mauleon

Contractual conditions, working conditions and their impact on health and well-being pp. 429-444

Silvana Robone, Andrew Jones and Nigel Rice

Comparing top-down and bottom-up costing approaches for economic evaluation within social welfare pp. 445-453

Tina Olsson

Cost of low back pain in Switzerland in 2005 pp. 455-467

Simon Wieser, Bruno Horisberger, Sara Schmidhauser, Claudia Eisenring, Urs Brügger, Andreas Ruckstuhl, Jürg Dietrich, Anne Mannion, Achim Elfering, Özgür Tamcan and Urs Müller

Ageing and health care expenditure in EU-15 pp. 469-478

Mickael Bech, Terkel Christiansen, Ehsan Khoman, Jørgen Lauridsen and Martin Weale

Atrial fibrillation: the cost of illness in Sweden pp. 479-487

Lisa Ericson, Lennart Bergfeldt and Ingela Björholt

Cost-effectiveness of cognitive-behavioral group therapy for dysfunctional fear of progression in cancer patients pp. 489-497

C. Sabariego, M. Brach, P. Herschbach, P. Berg and G. Stucki

Volume 12, issue 4, 2011

What values do the public want their health care systems to use in evaluating technologies? pp. 285-288

Martin Buxton and James Chambers

Estimates of patient costs related with population morbidity: can indirect costs affect the results? pp. 289-295

M. Carreras, Manuel García-Goñi, P. Ibern, J. Coderch, L. Vall-Llosera and J. Inoriza

Incentives in primary care and their impact on potentially avoidable hospital admissions pp. 297-309

Gianluca Fiorentini, Elisa Iezzi, Matteo Lippi Bruni and Cristina Ugolini

The costs of breast cancer prior to and following diagnosis pp. 311-317

Steven Broekx, Elly Hond, Rudi Torfs, Anne Remacle, Raf Mertens, Thomas D’Hooghe, Patrick Neven, Marie-Rose Christiaens and Steven Simoens

Resource use and costs of treating acute cough/lower respiratory tract infections in 13 European countries: results and challenges pp. 319-329

Raymond Oppong, Joanna Coast, Kerry Hood, Jacqui Nuttall, Richard Smith and Christopher Butler

Age effects in monetary valuation of reduced mortality risks: the relevance of age-specific hazard rates pp. 331-344

Andrea Leiter

Health burden and costs of obesity and overweight in Germany pp. 345-352

A. Konnopka, M. Bödemann and H.-H. König

Additional costs of inpatient malnutrition, Victoria, Australia, 2003–2004 pp. 353-361

David Rowell and Thomas Jackson

Cost study of the clinical management of prostate cancer in France: results on the basis of population-based data pp. 363-371

Laurent Molinier, Christel Castelli, Eric Bauvin, Xavier Rebillard, Michel Soulié, Jean-Pierre Daurès and Pascale Grosclaude

Factors associated with the use of primary care services: the role of practice nurses pp. 373-381

Laura Vallejo-Torres and Stephen Morris

The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure pp. 383-391

Nick Kontodimopoulos, Michalis Argiriou, Nikolaos Theakos and Dimitris Niakas

Volume 12, issue 3, 2011

To model or not to model: lessons from two vaccinations pp. 189-191

Livio Garattini and Anna Padula

Analysis of physicians’ perspectives versus patients’ preferences: direct assessment and discrete choice experiments in the therapy of multiple myeloma pp. 193-203

Axel Mühlbacher and Matthias Nübling

Modelling the costs of care of hypertension in patients with metabolic syndrome and its consequences, in Germany, Spain and Italy pp. 205-218

Eberhard Wille, Jürgen Scholze, Eduardo Alegria, Claudio Ferri, Sue Langham, Warren Stevens, David Jeffries and Kerstin Uhl-Hochgraeber

Utilities and disutilities for attributes of injectable treatments for type 2 diabetes pp. 219-230

Kristina Boye, Louis Matza, Kimberly Walter, Kate Brunt, Andrew Palsgrove and Aodan Tynan

Practical issues in handling data input and uncertainty in a budget impact analysis pp. 231-241

M. Nuijten, T. Mittendorf and U. Persson

Deriving reference values and utilities for the QoL-AGHDA in adult GHD pp. 243-252

J. Busschbach, B. Wolffenbuttel, L. Annemans, W. Meerding and M. Kołtowska-Häggström

Economic evaluation of irbesartan in combination with hydrochlorothiazide in the treatment of hypertension in Greece pp. 253-261

Nikos Maniadakis, Mattias Ekman, Vasilios Fragoulakis, Vasiliki Papagiannopoulou and John Yfantopoulos

Reimbursement of pharmaceuticals: reference pricing versus health technology assessment pp. 263-271

Michael Drummond, Bengt Jönsson, Frans Rutten and Tom Stargardt

Health care costs and their predictors of inflammatory bowel diseases in Germany pp. 273-283

Anne Prenzler, Bernd Bokemeyer, J.-Matthias Schulenburg and Thomas Mittendorf

Volume 12, issue 2, 2011

Relative effectiveness and the European pharmaceutical market pp. 97-102

Bengt Jönsson

The effect of alcoholic beverage excise tax on alcohol-attributable injury mortalities pp. 103-113

Chong Son and Kudret Topyan

Technical efficiency in primary health care: does quality matter? pp. 115-125

Luis Murillo-Zamorano and Carmelo Petraglia

Economic policies for healthier food intake: the impact on different household categories pp. 127-140

Jonas Nordström and Linda Thunstrom

Analysis of the validity of the vignette approach to correct for heterogeneity in reporting health system responsiveness pp. 141-162

Nigel Rice, Silvana Robone and Peter Smith

Severity as an independent determinant of the social value of a health service pp. 163-174

Jeff Richardson, John McKie, Stuart Peacock and Angelo Iezzi

Trust on doctor, social capital and medical care use of the elderly pp. 175-188

Jae-Young Lim, Hyun-Hoon Lee and Yeon-Hee Hwang

Volume 12, issue 1, 2011

Letter from the editors pp. 1-1

Johann Graf von der Schulenburg and Wolfgang Greiner

Public health care providers and market competition: the case of Finnish occupational health services pp. 3-16

Eila Kankaanpää, Ismo Linnosmaa and Hannu Valtonen

Inequalities in the use of health services between immigrants and the native population in Spain: what is driving the differences? pp. 17-28

Dolores Jiménez-Rubio and Cristina Hernández-Quevedo

Health care expenditures and gross domestic product: the Turkish case pp. 29-38

Seher Sülkü and Asena Caner

Optimal deductibles for outpatient services pp. 39-47

Karl-Michael Ortmann

Generic substitution: micro evidence from register data in Norway pp. 49-59

Dag Dalen, Kari Furu, Marilena Locatelli and Steinar Strøm

Social health inequalities among older Europeans: the contribution of social and family background pp. 61-77

Sandy Tubeuf and Florence Jusot

Risk and uncertainty in health investment pp. 79-85

Takao Asano and Akihisa Shibata

Preferences for health insurance and health status: does it matter whether you are Dutch or German? pp. 87-95

Janet Vroomen and Peter Zweifel